US Patent 11850229 Treatment of circadian rhythm disorders
Patent 11850229 was granted and assigned to Vanda Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+262 characters)
US Patent 11850229 Treatment of circadian rhythm disorders
Article
Patent abstract
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
John Joseph Feeney0
Louis William Licamele0
Marlene Michelle Dressman0
Mihael H. Polymeropoulos0
Date of Patent
December 26, 2023
0Patent Application Number
176512310
Date Filed
February 15, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11850229 Treatment of circadian rhythm disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
